Lupin Profit & Loss Annual

Trade
BSE: 500257 | NSE: LUPIN | ISIN: INE326A01037 | Sector: Biotechnology & Drugs
889.05 +8.25 (0.94%)Updated : 28 Jun 2023
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 20,010.8216,641.6616,405.4815,162.96
Total Revenue 20,010.8216,641.6616,405.4815,162.96
Costof Revenue Total 6,643.477,702.997,486.115,905.20
Gross Profit 13,367.358,938.678,919.379,257.76
Selling/ General/ Admin Expenses Total 3,494.577,019.526,625.436,556.71
Depreciation/ Amortization 1,196.81841.31818.50887.41
Other Operating Expenses Total 6,072.77156.81150.84122.82
Total Operating Expense 17,407.6215,760.0117,799.4713,472.14
Operating Income 2,603.20881.65-1,393.991,690.82
Interest Inc( Exp) Net- Non- Op Total -3,011.00-1,312.80-93.40-328.80
Other Net 120.17-54.8631.1217.58
Net Income Before Taxes 2,422.27716.49-1,372.211,676.45
Provisionfor Income Taxes 486.70268.80137.15448.52
Net Income After Taxes 1,935.57447.69-1,509.361,227.93
Minority Interest -21.09-17.61-18.68-11.40
Net Income Before Extra Items 1,914.48430.08-1,528.041,216.53
Net Income 1,914.48430.08-1,528.041,216.53
Income Availableto Com Excl Extra Ord 1,914.48430.08-1,528.041,216.53
Income Availableto Com Incl Extra Ord 1,914.48430.08-1,528.041,216.53
Diluted Net Income 1,914.48430.08-1,528.041,216.53
Diluted Weighted Average Shares 45.7245.6945.4045.52
Diluted EPS Excluding Extra Ord Items 41.879.41-33.6526.72
DPS- Common Stock Primary Issue 8.004.004.006.50
Diluted Normalized EPS 41.879.665.2626.71
Unusual Expense( Income) -39.382,718.590.00
Gain( Loss)on Saleof Assets -209.800.009.30
Total Extraordinary Items ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,764.00+15.75(0.90%)
1,403.00+9.85(0.71%)
3,484.35+22.70(0.66%)
7,220.00-12.45 (-0.17%)
HomeMarketsPremiumInstant LoanGet App